Exclusive: Baidu's Kunlunxin, valued at close to $3 billion, eyes Hong Kong IPO, sources say

Kunlunxin, Baidu's AI chip unit, completed a funding round raising over 2 billion yuan at a valuation of about 21 billion yuan and is planning a Hong Kong IPO targeted by early 2027 with a possible listing application in Q1 2026. The unit expects revenue to exceed 3.5 billion yuan this year and to reach break-even after posting about a 200 million yuan net loss on roughly 2 billion yuan revenue in 2024; over half of 2025 revenue is projected to come from external sales. Its P800 data‑centre chip has seen traction with state projects, and new M100 (inference, early 2026) and M300 (training+inference, early 2027) chips were unveiled, positioning Kunlunxin as a domestic alternative amid U.S. export restrictions on advanced GPUs.

Analysis

Market structure: Kunlunxin's IPO signal accelerates Beijing-backed domestic GPU supply growth and reduces Chinese demand dependence on Nvidia over 12–36 months; incumbents benefiting most are Baidu (BIDU) via asset re‑rating and local foundries/equipment suppliers, while Nvidia (NVDA) faces incremental demand risk in China (single‑digit EPS downside over 12–24 months if substitution accelerates). Expect price competition in inference/edge segments (5–20% ASP compression vs imported chips) but continued NVIDIA dominance at the bleeding edge for 2–3 years due to ecosystem lock‑in.

Risk assessment: Tail risks include US secondary blacklisting of Chinese chip issuers, Kunlunxin product underperformance versus NVDA (technical parity not achieved by 2027), or Baidu divestiture dynamics that dilute value — any of which could swing IPO valuation ±30–50%. Near term (days–weeks) volatility will track Moore Threads listing sentiment; short term (months) hinge on HK filing cadence and product launches (M100 in early 2026); long term (2–5 years) depends on fabs/access to process nodes and US export policy shifts.

Trade implications: Favor event-driven exposure to BIDU ahead of a potential 2026 HK filing (expect catalyst window Q1–Q3 2026) and hedge semiconductor beta with NVDA downside protection; exploit A‑share froth in GPU listings (Moore Threads) with short/mean‑reversion trades if >3x post‑IPO moves. Cross‑asset: anticipate modest RMB appreciation and tighter onshore credit spreads if state capex accelerates — overweight 3–7y CN sovereigns for 6–12 months.

Contrarian angles: Consensus underestimates manufacturing and toolchain gaps — Kunlunxin valuation (≈21bn CNY) implies ~6x 2025 revenue if revenue hits 3.5bn, which may be generous versus technical maturity; market may be overpricing near‑term growth (Moore Threads 5x IPO move as a cautionary signal). Unintended consequence: rapid listing wave could attract regulatory scrutiny in HK and increase fund flows out of foreign semis into domestic players, creating short‑term dislocations but longer‑term performance dispersion.

Key Decisions for Investors

• Establish a 2–3% long position in BIDU (NASDAQ/HK listing) within the next 30–90 days to capture potential re‑rating from Kunlunxin IPO activity; target +25–40% upside over 12 months, set a 12% stop‑loss and trim half on any >30% move.
• Buy a 6–12 month NVDA protective put spread to hedge semiconductor downside: buy 6‑month 10% OTM puts and sell 20% OTM puts (size ~0.5–1% portfolio notional) to cap cost; initiate if NVDA implied vol >35% or if US export guidance tightens in next 30 days.
• Short Moore Threads (688795.SS) or similar frothy Chinese GPU listings equal to 0.5–1% notional when price >3x IPO price or P/S >10x trailing revenue, using cash‑secured short or put purchase; exit on mean reversion or after 30% adverse move.
• Overweight Chinese onshore sovereign bonds (duration 3–7 years) by +2% allocation for 6–12 months and buy 6–12 month USD/CNH forwards (size 1–2% notional) if USD/CNH >7.08 to capture likely policy support and modest RMB appreciation tied to domestic semiconductor capex.